FDA Approves First Dietary Supplement under New Drug Application with the Indication of Serious or Life-Threatening Illnesses

Abstract

Background: Research began on botanical/herbal organisms to study plant cells. The idea behind this was that plant cells have basic similar actions as do animal cells (i.e., both are Eukaryotic cells). These cells can show what activity is produced from the Technology/Innovation behind ImunStem, without risk to animals or humans, and still retrieve data to verify the theory. By using plants and studying plant cell activity, then later comparing plant cell, animal cells, and human cell responses, it thus shows activity for all cell structures. The activity was also studied from patients taking ImunStem for the indication of Serious or Life-threatening conditions or diseases. Patient medical report results showed an overall improvement in bodily function as blood report results were compared. Patients that were administered ImunStem showed improvement in their overall health and patients with chronic disease had reduced pain as ImunStem was administered over time. The pain was reduced because the body was in the healing process and a reduction in inflammation would occur during healing and the patient's health would improve. ImunStem was produced based on the theory that the product could rejuvenate the cell and bring the cell back to a homeostasis balance. This balance to the cell (through nutrition) can give the surrounding cells a homeostasis balance that may heal cells and tissues in the body. It is believed that the function of a Quantum Wave effect is explained through the discipline of Quantum Mechanics. The Quantum Wave may disrupt the subatomic particles that provide adhesion to allow the product through the cell wall and move to its target location. In Quantum Mechanics, particles have wavelike properties. The Schrödinger equation, for example, governs how these waves behave. Methods: Administration of ImunStem was given to patients in a life-threatening situation where no standard acceptable treatment was available and in which there was not sufficient time to obtain approval from the Institutional How to cite this paper: Tieu, H.S. and Loeffler, M.F.

Patient Quality-of-Life, Providers with Incentive Payments, Real-World Evidence, and Reducing Healthcare Costs through New Innovations

“…This is very important for Medicare and Insurance Companies to reduce costs for patient treatment and is a "must" for the program to be successful. Golden Sunrise Innovation patients' medical report background and results [11] to support Value-Based Care program. 3).…”

Huu S. TIEU’s Predicting Outcome of Severe Acute Respiratory Syndrome (SARS) and Preparing the Treatment for COVID-19 (Coronavirus) and Other Viral Pandemics

“…Even a short period of time of Hypoxia can cause effects that could damage soft tissues (soft tissues are described as, organ tissues, veins, arteries, etc.). The author theory predicts that if a viral infection is severe enough to cause Hypoxia or Localized Oxygen Deprivation, then it results in a cascade effect in the body, including organ failure and blood clotting [7] [8].…”

Huu S. TIEU Request for FDA to Establish Regenerating Human Cells as Law on December 13, 2016 President Barack H. Obama Singed the 21st Century CURES Act into FDA Regulation and Law

“…Huu S. TIEU and Golden Sunrise requested consideration for a new indication of Serious or Life-threatening conditions or disease and for new legislation to the FDA on November 24, 2009 through August 08, 2015 [6]. or diseases.…”